OREANDA-NEWS. On 17 July 2008 OAO Pharmacy Chain 36.6 [RTS:APTK; MICEX:RU14APTK1007] the leading Russian pharmaceutical retailer announced audited 2007 financial results prepared in accordance with the International Financial Reporting Standards (IFRS).

Highlights

Y-o-Y in 2007 Group’s consolidated sales increased by 64,7% and reached US\\$ 871,1 million

Sales in the retail unit grew by 74% and reached US\\$ 673,4 million, sales of the production unit, Veropharm, reached US\\$ 139,5 million (annual growth 39%), sales of other non-core businesses (including EMC) grew by 37,9% and reached US\\$ 58,2 million.

Consolidated Gross profit increased by 51,3% to reach US\\$ 277,5 million, 31,9% of consolidated revenues.

Consolidated EBITDA of the Group declined to -US\\$ 7,0 million;

Consolidated Net loss amounted to -US\\$ 99,4 million

The results are driven primarily by performance of the retail and production units of the Group.